Abstract
The behavioral effects of the histamine H1 antagonistsd- andl-chlorpheniramine and of the H2 antagonist zolantidine were determined in squirrel monkeys responding under a fixed-interval (FI) 3-min schedule of stimulus-shock termination. Althoughd-chlorpheniramine is known to be much more potent thanl-chlorpheniramine for antagonizing H1 receptor-mediated effects of histamine or displacing [3H]-mepyramine from histamine H1 receptors, similar doses of racemic chlorpheniramine and thed- andl-isomers (3.0–10.0 mg/kg) produced comparable increases in rates of responding. Zolantidine (1.0–17.0 mg/kg) did not alter or, at the highest dose, markedly decreased responding. These findings suggest that the psychomotor stimulant effects of chlorpheniramine involve actions other than the blockade of histamine H1 or H2 receptors. Selected H1 antagonists and cocaine are known to have comparable rateincreasing, reinforcing, and discriminative stimulus effects and, recently, the enantiomers of chlorpheniramine have been shown to displace [3H]-cocaine from binding sites in CNS with approximately equal potency. Possibly, such actions mediate behavioral effects common to H1 antagonists and cocaine.
References
Bergman J, Spealman RD (1986a) Some behavioral effects of histamine H1 antagonists in squirrel monkeys. J Pharmacol Exp Ther 239:104–110
Bergman J, Spealman RD (1986b) Modulation of behavioral effects of histamine H1 antagonists and cocaine by yohimbine. Pharmacologist 28:107
Bergman J, Spealman RD (1988) Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol. J Pharmacol Exp Ther 245:471–478
Calcutt CR, Ganellin CR, Griffiths R, Leigh BK, Maguire JP, Mitchell RC, Mylek ME, Parsons ME, Smith IR, Young RC (1988) Zolantidine (SK & F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist. Br J Pharmacol 93:69–78
Carlsson A, Lindqvist M (1969) Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J Pharm Pharmacol 21:460–464
Chang RSL, Tran VT, Snyder SH (1979) Heterogeneity of histamine H1-receptors: species variations in [3H]mepyramine binding of brain membranes. J Neurochem 32:1653–1663
Green JP, Johnson CL, Weinstein H (1978) Histamine as a neurotransmitter. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 319–332
Griffiths R, Lee RM, Taylor DC (1977) Kinetics of cimetidine in man and experimental animals. In: Buland WI, Simkins MA (eds) Cimetidine: second international symposium on histamine H2 receptor antagonists. Royal College of Physicians, Experimental Medicine, Oxford, pp 38–53
Hill SJ, Emson PC, Young JM (1978) The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain. J Neurochem 31:997–1004
Horn AS, Coyle JT, Snyder SH (1970) Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Mol Pharmacol 7:66–80
McKearney JW (1982) Stimulant actions of histamine H1 antagonists on operant behavior in the squirrel monkey. Psychopharmacology 77:156–158
McKearney JW (1985) Relative potencies of histamine H1 antagonists as behavioral stimulants in the squirrel monkey. Psychopharmacology 86:380–381
Morse WH, Kelleher RT (1966) Schedules using noxious stimuli. I. Multiple fixed-ratio and fixed-interval termination of schedule complexes. J Exp Anal Behav 9:267–290
Reith MEA, Allen DL, Sershen H, Lajtha A (1984) Similarities and differences between high affinity binding sites for cocaine and imipramine in mouse cerebral cortex. J Neurochem 43:249–255
Roth FE, Govier WM (1958) Comparative pharmacology of chlorpheniramine (chlortrimeton) and its optical isomers. J Pharmacol Exp Ther 124:347–349
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergman, J. Psychomotor stimulant effects of the stereoisomers of chlorpheniramine. Psychopharmacology 100, 132–134 (1990). https://doi.org/10.1007/BF02245804
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245804